Tokyo, Oct. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063326) titled 'A study to evaluate the effectiveness and safety of tirzepatide injection in patients with type 2 diabetes' on Oct. 20.
Study Type:
Observational
Primary Sponsor:
Institute - Meitetsu hospital
Condition:
Condition - Type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to evaluate the effectiveness and safety of subcutaneous tirzepatide in patients with type 2 diabetes mellitus in clinical practice.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male a...